Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade
- 7 March 2009
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 33 (3) , 460-464
- https://doi.org/10.1016/j.leukres.2008.08.021
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cellsBlood, 2008
- CD200 as a prognostic factor in acute myeloid leukaemiaLeukemia, 2007
- CD200 is a new prognostic factor in multiple myelomaBlood, 2006
- Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulationProceedings of the National Academy of Sciences, 2006
- MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytesExperimental Hematology, 2006
- Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cellsBlood, 2005
- Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabineBlood, 2005
- Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cellsJournal of Clinical Investigation, 2005
- Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytesBlood, 2005
- Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 miceClinical and Experimental Immunology, 2001